STACIE BULLOCK: Open Payments
NPI 1174802565 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 23 payments from 9 companies in 2025. Trend: 2023 $945 · 2024 $654 · 2025 $711
Food & beverage: $521Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $208 |
| Sumitomo Pharma America, Inc. | 6 | $114 |
| Medtronic, Inc. | 4 | $112 |
| Kerecis Limited | 2 | $90 |
| ABBVIE INC. | 3 | $70 |
| Boston Scientific Corporation | 1 | $36 |
| Verity Pharmaceuticals Inc. | 2 | $34 |
| Antares Pharma, Inc. | 1 | $26 |
| Davol Inc. | 1 | $22 |
Products named: ERLEADA, INTERSTIM, Kerecis SurgiClose, BOTOX, GEMTESA, ORGOVYX, Moses, Tlando.
Industry payments across AL — which companies pay providers there.
